SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Shasun has informed that the Exchange vide letter dated April 06, 2016 that they refer to the interview with Rajiv Malik, President of Mylan, published by Economic Times on April 5, 2016 (online edition), in which it was mentioned that Arbitration is going on in London. They wish to clarify that, as on date, there is no arbitration proceeding under way between Mylan and Strides. They had intimated to the Stock Exchanges regarding the Notification of Claims received from Mylan, on December 15, 2015. Since then there are no developments that require any further intimation to the Stock Exchanges.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

1081.80 7.95 (0.74%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: